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Introduction
Bariatric surgery elicits a potent improvement in the metabolic
state of obese subjects with type 2 diabetes [1], and the effects
on diabetes remission and long-term weight loss have been de-
scribed in several randomized trial reports and systematic re-
views [2–4]. However, bariatric surgery is associated with se-
vere adverse events, rendering it unappealing for many pa-
tients [5–7]. Novel minimally invasive procedures with more
favorable safety and tolerability profiles are being developed
to elicit the metabolic benefits of bariatric surgery.
Duodenal mucosal resurfacing (DMR) is a minimally invasive
endoscopic procedure using hydrothermal ablation. The duo-
denal mucosa layer is thought to play a key role in metabolic
homeostasis. Results from animal and human studies have
demonstrated that bypass of the duodenum elicits insulin-sen-
sitizing effects that appear to be weight independent, and
acute reintroduction of nutrients into the bypassed foregut
can cause a lapse to the presurgery dysmetabolic state [8, 9].
Preclinical and clinical effectiveness and safety of DMR were
previously reported [10, 11]. Herein we describe local tissue
changes after acute hydrothermal mucosal ablation in the pig
duodenum, which has many anatomical similarities to humans,
but is not as thick and is more fragile.
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ABSTRACT
Background and study aims Minimally invasive proce-
dures that replicate aspects of bariatric surgery with more
favorable safety and tolerability offer an attractive alterna-
tive in management of metabolic disease. Duodenal muco-
sal resurfacing (DMR), an endoscopic procedure using hy-
drothermal ablation, is designed to remove surface epithe-
lium to allow subsequent epithelial regeneration and a reset
to a more insulin-sensitive state.
Materials and methods DMR was performed on a healthy
pig under general anethesia, approximating the procedure
designed for use in humans. Immediately post-DMR, analy-
sis of the histological landscape was conducted in distinct
duodenal areas that received ablation treatment.
Results DMR submucosal lift and hydrothermal ablation
elicited disruption of villous tips and partial disruption of
the crypt base with no damage to deeper tissue. Excessive
ablation (purposeful double ablation exposure) did incur
damage to the underlying muscle layer.
Conclusion Our results confirmed that DMR elicits super-
ficial ablation of duodenal villi and crypts. Defining the cel-
lular consequences of ablation and regeneration of the epi-
thelium will aid our understanding of how and why DMR af-
fects metabolic homeostasis.
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DMR was conducted at the Heart Institute of São Paulo Univer-
sity experimental laboratory in a live healthy pig (Danish Land-
race, male, ~176 lb) as part of animal laboratory training for the
ongoing clinical protocol (NCT02879383).
Under general anaesthesia, the procedure was performed
transorally using a pediatric colonoscope. The major duodenal
papilla was identified, and the opposite wall was marked with a
metal clip for fluoroscopic and endoscopic guidance to avoid
ampullary ablation. The Ligament of Treitz was surpassed, and
a stiff-shaft 0.035-inch guidewire was placed in the proximal je-
junum. The scope was then removed with the wire left in place.
A polyethylene terephthalate balloon catheter (Revita System,
Fractyl, Lexington, Massachusetts, United States; ▶Fig. 1a)
was then introduced over the wire using fluoroscopic and endo-
scopic guidance.
DMR was performed by first injecting saline plus methylene
blue solution into the submucosa layer to lift the mucosa away
from the underlying tissue. Submucosal injection was adminis-
tered by three auxiliary needles with vacuum devices that were
oriented in a 120-degree angle toward the intestinal wall that
allowed elevation of the mucosa circumferentially. Using
fluoroscopic guidance, the balloon (length 2 cm) was then infla-
ted with 82°C water for 10 seconds. Five longitudinal ablations
were performed, totalling 10 cm of duodenal mucosal ablation.
DMR was initiated in the descending portion 1 cm distal to the
papilla and continued up to the fourth portion. Overlapping ab-
lations were avoided. However, for training purposes, after the
fifth ablation, the third portion of the duodenum was reabla-
ted, producing distinct duodenal areas for later examination.
These included:
1. control tissue that did not undergo lift or ablation;
2. lifted tissue that did not undergo ablation;
3. tissue that underwent lifting and ablation; and
4. an area where lifting and double ablation had occurred.
Histological analysis and immunohistochemistry
Shortly after the procedure, the pig was euthanized according
to local animal ethics protocols [12], and the duodenum was re-
sected. Tissue was processed and histologically evaluated. Tis-
sues were fixed in 10% buffered formalin solution for 24 hours,
processed in crescent alcohol concentration series, diaphanized
in xylol, and embedded in paraffin. Paraffin blocks were cut into
5- to 8-µm-thick sections using a microtome. Sections were
stained with hematoxylin and eosin (HE) or Masson’s trichrome
stain to identify connective tissue and collagen fibers.
Sections were stained to evaluate the effect of DMR on the
crypt stem cell and transit amplifying epithelial zones. Sox-9
protein was detected on formalin-fixed, paraffin-embedded tis-
sue sections (5 µm) from all four regions. Sections were depar-
affinized in two 5-minute xylene-incubations, then hydrated
through a graded alcohol series (100%, 95%, 70%, water).
Heat-induced epitope retrieval with sodium citrate buffer for
20 minutes was applied before slides were incubated at room
temperature with 5µg/mL green-fluorescent Oregon Green
488 wheat germ agglutinin (WGA, Invitrogen, Carlsbad, Califor-
nia, United States) for 10 minutes. After blocking with 1% BSA/
5% donkey serum (1 hour), sections were incubated with poly-
clonal goat anti-Sox-9 (1:100; R +D Systems, Minneapolis, MN)
at 4°C overnight. Primary antibody was visualized using a don-
key anti-goat AlexaFluor594 (1:200; Jackson ImmunoResearch
Laboratories, West Grove, Pennsylvania, United States) and
counterstained with DAPI. Coverslips were mounted with Vec-
tashield Vibrance Antifade Mounting Medium (Vector Labora-
tories, Burlingame, California, United States). Images were col-
lected on an Eclipse Ti-E inverted microscope (Nikon Instru-
ments, Inc., Melville, New York, United States).
Results
In control sections, there were no gross signs of mucosal injury
(▶Fig. 1b). Defined villus structures with intact epithelial rib-
bons were clearly seen. Lectin WGA binds to sialic acid and N-
acetylglucosaminyl residues, highlighting secretory granules
and mucus, weakly staining cell membranes. Mucus-producing
goblet cells were scattered throughout the intact epithelium of
controls and mucus was also in the crypts (▶Fig. 2a, ▶Fig. 2b).
SOX-9 is primarily expressed by intestinal stem cells and transit-
amplifying (TA) progenitor cells, but it is also present in termin-
ally differentiated endocrine cells. In controls, Sox-9 detected
cells in the small intestine crypts base, consistent with the
stem and TA zones with distinct nuclear localization in all posi-
tive cells (▶Fig. 2a, ▶Fig. 2b).
In areas where the mucosa was lifted and thermal ablation
was applied, there was striking submucosal edema associated
with superficial mucosal necrosis involving the tips of the villi
(▶Fig. 1c). WGA staining of epithelial mucus (associated with
goblet cells) was absent in areas of ablation as was luminal
staining of secreted mucus within the crypts (▶Fig. 2c, ▶Fig.
2d). Sox-9 staining generally appeared weaker than in control
sections, suggesting some disruption of the crypt base, but
the stem and TA zones were still identifiable. Architecturally,
the base of the crypts seemed relatively intact but with areas
of disruption of the morphology in lower portions of some
crypts (▶Fig. 2c, ▶Fig. 2d).
In sections where the epithelium had been lifted but not ab-
lated, the submucosal edema was obvious and the mucosal lay-
er appeared indistinguishable from control section (▶Fig. 1 d).
In WGA-stained mucus and mucus-containing goblet cells, Sox-
9 highlighted intact and strong staining of the stem and TA
zones (▶Fig. 2e, ▶Fig. 2f).
In areas where double ablation was performed, we observed
an increased level of damage compared with areas where single
ablation was performed. Besides the mucosal injury, we found
submucosal edema and severe congestion of the serosal ves-
sels, which was associated with segmental necrosis of the mus-
cularis propria (▶Fig. 1e, ▶Fig. 1f), with neutrophilic infiltra-
tion reaching the serosa. Necrosis of the muscular layer accom-
panied by edema of the submucosa and hemorrhage of the ser-
osa was also visible (▶Fig. 1g). WGA staining of goblet-like cells
and mucus was absent and Sox-9 staining was weak or absent.
















































▶ Fig. 1 Effect of duodenal mucosal resurfacing on the epithelium. a Revita balloon catheter used for duodenal mucosal resurfacing. Auxiliary
needles vacuum devices (black arrows) and balloon (yellow arrow) (Fractyl Laboratories, Inc., Waltham, Massachusetts, United States). A series
of photomicrographs depicting the gross histology by H&E staining of the four experimental regions is presented. b Control duodenal wall
from a nonablated segment. The mucosa, submucosa, and muscular layers are preserved. c Lifted and ablated mucosa showing recent necrosis
of the cells at the tips of the villi (arrows) and severe edema of the submucosal layer (asterisks). d Lifted and nonablated duodenal wall showing
preserved epithelium and edema of the submucosal layer (asterisks). e Overlap ablation showing mucosal injury (necrosis, arrows), and sub-
mucosal edema and severe congestion of the serosal vessels (open arrows). f The external muscular layer of the duodenal wall from overlap
ablation showing areas of necrosis of the muscular layer (asterisk), vascular congestion and neutrophilic infiltration (arrows). g The external
muscular layer following overlap ablation showing focal necrosis (discontinuity of the smooth-muscle cell fibers [asterisks]) using Masson’s
trichrome stain. Edema and hemorrhage of the serosa are evident.















































▶ Fig. 2 Effect of duodenal mucosal resurfacing on the stem and transit-amplifying zones of the epithelium.
Continuation see following page
















































There was obvious disruption of the stem and TA zones in most
of the areas receiving overlap ablation, which equated to the in-
creased damage observed in H&E-stained sections (▶Fig. 2g,
▶Fig. 2h).
Discussion
Procedures that bypass the duodenum promote an immediate
and long-term anti-diabetic effect before significant weight
loss occurs [13–15], placing the gut front and center in dia-
betes pathology and treatment. The mechanisms by which by-
passing the duodenum leads to metabolic improvements are
not fully understood. Uncovering the mechanisms leading to
favorable metabolic changes observed could lead to novel
treatments for type 2 diabetes and related metabolic disease.
Despite the effectiveness of bariatric surgery, less invasive
alternatives that recapitulate some metabolic benefits of sur-
gery are highly sought after. DMR is a promising alternative. Re-
cent studies report glycemic improvement with an average re-
duction in HbA1c of 1.0% to 1.2% at 6 months and 1-year post-
DMR, respectively [10, 11]. How DMR elicits glycemic improve-
ment is currently unknown. The working hypothesis proposes
that DMR ablation of the superficial mucosa elicits epithelial re-
generation, resetting to a more insulin-sensitive state [8].
Histologic assessment of the duodenal epithelium following
DMR is an important step to linking superficial epithelial abla-
tion, its subsequent regeneration, and the beneficial effect on
glucose homeostasis. We confirmed that DMR promotes super-
ficial mucosal ablation of the villus tips to the crypt base while
also observing that the submucosal lift creates a submucosal
barrier protection against deeper tissue injury. Results from
the first-in-human DMR study found a positive correlation be-
tween ablation length and degree of improvement in HbA1c
[10]. The standard DMR procedure likely leaves small gaps of
preserved mucosa between the ablation sites produced by the
catheter design, but this does not appear to negatively impact
DMR’s outcomes.
Conclusion
Our results suggest that in the pig duodenum, thermal injury
could reach the muscularis propria if overlap ablation is applied,
increasing risk of duodenal stricture. Therefore, overlaps should
be avoided.
Future studies on effect of DMR on the duodenal stem cell
population, which seeds the rest of the epithelium, are needed.
Understanding the DMR mechanism of action will shed new
light on intestinal cell biology and its pathology in diabetes
and obesity. A large sham-controlled trial is ongoing to assess
efficacy and safety of DMR in humans.
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